These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3771152)

  • 1. Ytterbium-DTPA. A potential intravascular contrast agent.
    Unger E; Gutierrez F
    Invest Radiol; 1986 Oct; 21(10):802-7. PubMed ID: 3771152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs.
    Schmitz SA; Wagner S; Schuhmann-Giampieri G; Krause W; Bollow M; Wolf KJ
    Radiology; 1997 Nov; 205(2):361-6. PubMed ID: 9356615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography with iodine-free contrast media.
    Zwicker C; Hering M; Langer R
    Eur Radiol; 1997; 7(7):1123-6. PubMed ID: 9265688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular CT blood pool contrast agent.
    Vera DR; Mattrey RF
    Acad Radiol; 2002 Jul; 9(7):784-92. PubMed ID: 12139092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of iodinated and noniodinated contrast media in computed tomography.
    Zwicker C; Langer M; Langer R; Keske U
    Invest Radiol; 1991 Nov; 26 Suppl 1():S162-4; discussion S165-6. PubMed ID: 1808117
    [No Abstract]   [Full Text] [Related]  

  • 6. [CT contrast administration of iodine, gadolinium and ytterbium. In-vitro studies and animal experiments].
    Zwicker C; Langer M; Urich V; Felix R
    Rofo; 1993 Mar; 158(3):255-9. PubMed ID: 8453080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of Gd-DTPA as a CT contrast agent in the renal tract.
    Gibson RJ; Meanock CI; Torrie EP; Walker TM
    Clin Radiol; 1993 Apr; 47(4):278-9. PubMed ID: 8495577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of gadolinium-diethylene triamine pentaacetic acid enhanced multidetector computed tomography for the evaluation of coronary artery disease.
    Carrascosa P; Capuñay C; Bettinotti M; Goldsmit A; Deviggiano A; Carrascosa J; García MJ
    J Cardiovasc Comput Tomogr; 2007 Oct; 1(2):86-94. PubMed ID: 19083885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of enhancement, image quality, cost, and adverse reactions using 2 different contrast medium concentrations for routine chest CT on 16-slice MDCT.
    Setty BN; Sahani DV; Ouellette-Piazzo K; Hahn PF; Shepard JA
    J Comput Assist Tomogr; 2006; 30(5):818-22. PubMed ID: 16954936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT Image Contrast of High-Z Elements: Phantom Imaging Studies and Clinical Implications.
    FitzGerald PF; Colborn RE; Edic PM; Lambert JW; Torres AS; Bonitatibus PJ; Yeh BM
    Radiology; 2016 Mar; 278(3):723-33. PubMed ID: 26356064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography].
    Engelbrecht V; Koch JA; Rassek M; Mödder U
    Rofo; 1996 Jul; 165(1):24-8. PubMed ID: 8765359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological behavior of 169 Yb-DTPA after intrathecal administration.
    DeLand FH
    J Nucl Med; 1973 Feb; 14(2):93-8. PubMed ID: 4739174
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours.
    Carr DH; Brown J; Bydder GM; Weinmann HJ; Speck U; Thomas DJ; Young IR
    Lancet; 1984 Mar; 1(8375):484-6. PubMed ID: 6142210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 70 kVp computed tomography pulmonary angiography: potential for reduction of iodine load and radiation dose.
    Wichmann JL; Hu X; Kerl JM; Schulz B; Frellesen C; Bodelle B; Kaup M; Scholtz JE; Lehnert T; Vogl TJ; Bauer RW
    J Thorac Imaging; 2015 Jan; 30(1):69-76. PubMed ID: 25423130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prototype liver-specific contrast medium for CT: preclinical evaluation of gadoxetic acid disodium, or Gd-EOB-DTPA.
    Schmitz SA; Wagner S; Schuhmann-Giampieri G; Krause W; Wolf KJ
    Radiology; 1997 Feb; 202(2):407-12. PubMed ID: 9015066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.
    Weinmann HJ; Brasch RC; Press WR; Wesbey GE
    AJR Am J Roentgenol; 1984 Mar; 142(3):619-24. PubMed ID: 6607655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis and screening of nonionic gadolinium (III) DTPA-bisamide complexes as magnetic resonance imaging contrast agents.
    Periasamy M; White D; deLearie L; Moore D; Wallace R; Lin W; Dunn J; Hirth W; Cacheris W; Pilcher G
    Invest Radiol; 1991 Nov; 26 Suppl 1():S217-20; discussion S232-5. PubMed ID: 1667003
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preclinical investigation of Mn(II)-diethylenetriaminepentaacetate (Mangapentetate) as paramagnetic contrast agent for magnetic resonance tomography].
    Usov VIu; Belianin ML; Karpova GV; Borodin OIu; Filimonov VD
    Eksp Klin Farmakol; 2008; 71(4):41-6; discussion 47-8. PubMed ID: 18819440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the iodine concentration that yields the highest intravascular enhancement in MDCT angiography.
    Behrendt FF; Pietsch H; Jost G; Palmowski M; Günther RW; Mahnken AH
    AJR Am J Roentgenol; 2013 May; 200(5):1151-6. PubMed ID: 23617503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-DTPA as a high-performance CT contrast agent for in vivo imaging.
    Liao W; Lei P; Pan J; Zhang C; Sun X; Zhang X; Yu C; Sun SK
    Biomaterials; 2019 May; 203():1-11. PubMed ID: 30844678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.